Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
leukemia
Pharma
Syndax strikes $350M funding deal with Royalty Pharma
To help foot the bill for two commercial launches, Syndax Pharmaceuticals has struck a $350 million deal with Royalty Pharma.
Kevin Dunleavy
Nov 5, 2024 10:50am
Novartis' Scemblix leaps into newly diagnosed CML
Oct 29, 2024 3:56pm
Brazil taps nonprofit to slash cell therapy production costs
Mar 26, 2024 8:44am
BMS settles with Xspray, clearing way for 2024 Dasynoc launch
Sep 12, 2023 10:16am
FDA rejects Xspray's would-be rival to BMS leukemia med Sprycel
Jul 11, 2023 9:55am
Particulates have prompted yet another injectable drug recall
Mar 30, 2022 9:45am
